FIELD: chemistry.
SUBSTANCE: disclosed is a N-vinyl pyrrolidone-based copolymer of general formula (I): 
, where the monomer link M1 represents a fragment of 2-methyl-5-vinyl pyridine (MVP), and the monomer link M2 represents a fragment of 4-vinyl pyridine (VP): 
M1, (MVP) 
M2, (VP); content of monomer links M1 and M2 (m+k) is equal to 20-90 mol %, wherein the content of monomer links M2 (k) is equal to 0.05-(m+k)-0.30·(m+k), and the viscosity-average molecular weight Mµ of the copolymer Mµ=15-250 kDa. Also disclosed is use of said copolymer as an activator for producing interleukin-1, an agent against liver, kidney, urinary bladder, bone marrow and breast cancer, as a phagocytosis activator and as an adjuvant when influenza vaccines.
EFFECT: disclosed copolymer widens the range of biologically active compounds based on copolymers of N-vinyl pyrrolidone and has a wide range of action compared to existing analogues.
9 cl, 6 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COPOLYMERS OF 2-METHYL-5-VINYL-PYRIDINE AND N-VINYL PYRROLIDONE, HAVING PHAGOCYTOSIS ACTIVATOR PROPERTIES | 2010 |
|
RU2430933C1 |
| COPOLYMERS OF 4-VINYLPYRIDINE OR 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE WITH TERMINAL CYANOVALERIC ACID RESIDUE AND USE THEREOF TO TREAT PNEUMOCONIOSIS | 2014 |
|
RU2550820C1 |
| COPOLYMERS OF 2-METHYL-5-VINYL-PYRIDINE AND N-VINYLPYRROLIDONE, ACTIVATING PRODUCTION OF INTERLEUKIN-1, AND USE THEREOF AS ANTI-CANCER AGENTS | 2010 |
|
RU2430932C1 |
| N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
| N-VINYLPYRROLIDONE BASED COPOLYMERS | 2010 |
|
RU2415876C1 |
| USE OF N-VINYLPYRROLIDONE COPOLYMER AS AGENT POTENTIATING ANALGESIC EFFECT OF MORPHINE HYDROCHLORIDE | 2011 |
|
RU2471491C1 |
| OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES AND POLY(N-VINYLPYRROLIDONE) | 2012 |
|
RU2509562C1 |
| MEDICINAL AGENT BASED ON SYNTHETIC COPOLYMER OF VINYLPYRIDINE ROW FOR TREATING TISSUE HELMINTHIASIS | 2019 |
|
RU2727935C1 |
| INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
| OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES | 2012 |
|
RU2510264C1 |
